2019 - 2013:  Dr. Sandra Pinto was PhD student at the University of Lisbon. A significant portion of her PhD was carried out at the Weizmann Institute of Science. During her PhD, she acquired strong multidisciplinary training on chemistry, state-of-the-art biophysics methodologies (e.g. Fluorescence Spectroscopy and microscopy) and cell biology which are of great assistance for the characterization of cellular mechanisms related with the action of novel antibiotics.

 

2013: Postdoctortoral Researcher at Instituto de Medicina Molecular João Lobo Antunes (IMM). There she started studying viral-derived peptides with biomedical interest.

​

2015: Postdoctortoral Researcher at Instituto Superior Técnico (IST). Continuing the same project, she implemented and optimized advanced fluorescence imaging methods, aiming to characterize bacterial biofilm structure during treatment with antimicrobial agents. In the same research line, she has also identified novel class of synthetic mimics of AMPs (patent PT 116802) and preformed collaborative work that resulted in the development of carbon nanodots that can be applied to assist the characterization of bacterial biofilm matrix.

​

2018: Research Assistant at Instituto Superior Técnico (IST). Recently she initiated as co-PI a new funded (Research Grant 2019) project Tackling multiple myeloma by osteoblast cross-regulation OSTEOGLUTIS. The project won 3rd edition of the Multiple Myeloma.

​

2019: Joined the Institute for Bioengineering and Biosciences (iBB) 

​

2020: Guest Editor for Molecules (https://www.mdpi.com/journal/molecules/special_issues/nanotherapeutics, IF = 3,26)

​

She is also currently team member of 4 projects under IST leadership awarded with competitive grants.